Curis
CRIS
$15.01
Share price
1.08%
Change (1 day)
1,776.25%
Change (1 year)
Categories
Earnings for Curis (CRIS)
Earnings in 2023 (TTM): -$43.93 M
According to Curis's latest financial reports the company's current earnings (TTM) are -$43.93 M. an increase over its 2022 earnings that were of -$52.24 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Curis from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$43.93 M | -15.91% |
| 2022 | -$52.24 M | 27.52% |
| 2021 | -$40.97 M | 65.09% |
| 2020 | -$24.82 M | -9.1% |
| 2019 | -$27.3 M | -4.73% |
| 2018 | -$28.65 M | -41.95% |
| 2017 | -$49.36 M | -14.37% |
| 2016 | -$57.64 M | 3.55% |
| 2015 | -$55.66 M | 271.52% |
| 2014 | -$14.99 M | 76.64% |
| 2013 | -$8.49 M | |
| 2011 | -$7.21 M | 27.76% |
| 2010 | -$5.64 M | -43.87% |
| 2009 | -$10.05 M | -23.44% |
| 2008 | -$13.12 M | 56.66% |
| 2007 | -$8.38 M | -16.71% |
| 2006 | -$10.06 M | -36.92% |
| 2005 | -$15.94 M | 156.25% |
| 2004 | -$6.23 M | -37.24% |
| 2003 | -$9.92 M | -93.34% |
| 2002 | -$0.15 B | 86.79% |
| 2001 | -$79.68 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -7,537.34% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.44 B | -19,313.70% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -$61.89 M | 40.87% | 🇺🇸 USA |
 Exelixis EXEL | $0.25 B | -686.25% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.15 B | 223.36% | 🇺🇸 USA |
 Cel-Sci
CVM | -$30.33 M | -30.95% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.65 B | 1,365.61% | 🇺🇸 USA |